Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 3
2013 2
2014 3
2015 3
2016 4
2017 2
2018 1
2019 4
2020 5
2021 9
2022 21
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean morenafasano (1 results)?
Immunotherapy for head and neck cancer: Present and future.
Fasano M, Corte CMD, Liello RD, Viscardi G, Sparano F, Iacovino ML, Paragliola F, Piccolo A, Napolitano S, Martini G, Morgillo F, Cappabianca S, Ciardiello F. Fasano M, et al. Crit Rev Oncol Hematol. 2022 Jun;174:103679. doi: 10.1016/j.critrevonc.2022.103679. Epub 2022 Apr 6. Crit Rev Oncol Hematol. 2022. PMID: 35395371 Free article. Review.
Lymphomatoid papulosis.
Sica A, Vitiello P, Sorriento A, Ronchi A, Calogero A, Sagnelli C, Troiani T, Fasano M, Dodaro CA, Franco R, Casale B, Santangelo M, Ciccozzi M, Ciardiello F, Argenziano G, Moscarella E. Sica A, et al. Among authors: fasano m. Minerva Med. 2020 Apr;111(2):166-172. doi: 10.23736/S0026-4806.19.06395-X. Epub 2020 Jan 20. Minerva Med. 2020. PMID: 31958921 Review.
Circulating biomarkers in malignant pleural mesothelioma.
Viscardi G, Di Natale D, Fasano M, Brambilla M, Lobefaro R, De Toma A, Galli G. Viscardi G, et al. Among authors: fasano m. Explor Target Antitumor Ther. 2020;1(6):434-451. doi: 10.37349/etat.2020.00028. Epub 2020 Dec 28. Explor Target Antitumor Ther. 2020. PMID: 36046389 Free PMC article. Review.
Role and targeting of anaplastic lymphoma kinase in cancer.
Della Corte CM, Viscardi G, Di Liello R, Fasano M, Martinelli E, Troiani T, Ciardiello F, Morgillo F. Della Corte CM, et al. Among authors: fasano m. Mol Cancer. 2018 Feb 19;17(1):30. doi: 10.1186/s12943-018-0776-2. Mol Cancer. 2018. PMID: 29455642 Free PMC article. Review.
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab.
Martini G, Ciardiello D, Dallio M, Famiglietti V, Esposito L, Corte CMD, Napolitano S, Fasano M, Gravina AG, Romano M, Loguercio C, Federico A, Maiello E, Tuccillo C, Morgillo F, Troiani T, Di Maio M, Martinelli E, Ciardiello F. Martini G, et al. Among authors: fasano m. Int J Cancer. 2022 Aug 1;151(3):473-480. doi: 10.1002/ijc.34033. Epub 2022 Apr 29. Int J Cancer. 2022. PMID: 35429341 Free PMC article. Clinical Trial.
The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities.
Franzese E, Falco S, Laterza MM, Montella L, Facchini S, Liguori C, Coppola P, Diessa Y, Berretta M, Pisconti S, Trama F, Ferro M, Crocetto F, Fasano M, Buonerba C, Facchini G. Franzese E, et al. Among authors: fasano m. Future Sci OA. 2021 Apr 7;7(6):FSO705. doi: 10.2144/fsoa-2021-0035. Future Sci OA. 2021. PMID: 34046207 Free PMC article. No abstract available.
Mechanisms of resistance to EGFR-targeted drugs: lung cancer.
Morgillo F, Della Corte CM, Fasano M, Ciardiello F. Morgillo F, et al. Among authors: fasano m. ESMO Open. 2016 May 11;1(3):e000060. doi: 10.1136/esmoopen-2016-000060. eCollection 2016. ESMO Open. 2016. PMID: 27843613 Free PMC article. Review.
60 results